These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3457519)

  • 1. Neuromuscular involvement in glycogen storage disease type III.
    Moses SW; Gadoth N; Bashan N; Ben-David E; Slonim A; Wanderman KL
    Acta Paediatr Scand; 1986 Mar; 75(2):289-96. PubMed ID: 3457519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal and cardiac muscle involvement in children with glycogen storage disease type III.
    Mogahed EA; Girgis MY; Sobhy R; Elhabashy H; Abdelaziz OM; El-Karaksy H
    Eur J Pediatr; 2015 Nov; 174(11):1545-8. PubMed ID: 25948107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of glycogen in sural nerve axons in adult-onset type III glycogenosis.
    Ugawa Y; Inoue K; Takemura T; Iwamasa T
    Ann Neurol; 1986 Mar; 19(3):294-7. PubMed ID: 3457549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle Ultrasound in Patients with Glycogen Storage Disease Types I and III.
    Verbeek RJ; Sentner CP; Smit GP; Maurits NM; Derks TG; van der Hoeven JH; Sival DA
    Ultrasound Med Biol; 2016 Jan; 42(1):133-42. PubMed ID: 26437929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.
    Coleman RA; Winter HS; Wolf B; Gilchrist JM; Chen YT
    Ann Intern Med; 1992 Jun; 116(11):896-900. PubMed ID: 1580445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring.
    Halaby CA; Young SP; Austin S; Stefanescu E; Bali D; Clinton LK; Smith B; Pendyal S; Upadia J; Schooler GR; Mavis AM; Kishnani PS
    Genet Med; 2019 Dec; 21(12):2686-2694. PubMed ID: 31263214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The electrodiagnostic characteristics of Glycogen Storage Disease Type III.
    Hobson-Webb LD; Austin SL; Bali DS; Kishnani PS
    Genet Med; 2010 Jul; 12(7):440-5. PubMed ID: 20071996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III glycogenosis with multicore structures.
    Pellissier JF; de Barsy T; Faugere MC; Rebuffel P
    Muscle Nerve; 1979; 2(2):124-32. PubMed ID: 161799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different clinical aspects of debrancher deficiency myopathy.
    Kiechl S; Kohlendorfer U; Thaler C; Skladal D; Jaksch M; Obermaier-Kusser B; Willeit J
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):364-8. PubMed ID: 10449560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debrancher deficiency: neuromuscular disorder in 5 adults.
    DiMauro S; Hartwig GB; Hays A; Eastwood AB; Franco R; Olarte M; Chang M; Roses AD; Fetell M; Schoenfeldt RS; Stern LZ
    Ann Neurol; 1979 May; 5(5):422-36. PubMed ID: 288318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neuropathy in glycogen storage disease type III: Fact or myth?
    Herlin B; Laforět P; Labrune P; Fournier E; Stojkovic T
    Muscle Nerve; 2016 Feb; 53(2):310-2. PubMed ID: 26575860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.
    Oh SH; Park HD; Ki CS; Choe YH; Lee SY
    Clin Chem Lab Med; 2008; 46(9):1245-9. PubMed ID: 18785866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIa.
    Horvath JJ; Austin SL; Jones HN; Drake EJ; Case LE; Soher BJ; Bashir MR; Kishnani PS
    Mol Genet Metab; 2012 Nov; 107(3):496-500. PubMed ID: 23062577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of neuromuscular disorders in type III glycogenosis (Cori-Forbes disease)].
    Yamane K; Osawa M; Maruyama S; Haruta S; Sekiguchi M
    Rinsho Shinkeigaku; 1984 May; 24(5):453-62. PubMed ID: 6592067
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac involvement in glycogen storage disease type III.
    Moses SW; Wanderman KL; Myroz A; Frydman M
    Eur J Pediatr; 1989 Aug; 148(8):764-6. PubMed ID: 2792130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral nerve in type III glycogenosis: selective involvement of unmyelinated fiber Schwann cells.
    Powell HC; Haas R; Hall CL; Wolff JA; Nyhan W; Brown BI
    Muscle Nerve; 1985 Oct; 8(8):667-71. PubMed ID: 3864008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case of adult-onset type III glycogenosis].
    Ugawa Y; Inoue K; Takemura T
    Rinsho Shinkeigaku; 1983 Aug; 23(8):661-7. PubMed ID: 6420103
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of cornstarch therapy in type III glycogen-storage disease.
    Gremse DA; Bucuvalas JC; Balistreri WF
    Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
    Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse model of glycogen storage disease type III.
    Liu KM; Wu JY; Chen YT
    Mol Genet Metab; 2014 Apr; 111(4):467-76. PubMed ID: 24613482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.